Why SpringWorks Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket - argenx (NASDAQ:ARGX), Alithya Group (NASDAQ:ALYA)

Shares of SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) surged in pre-market trading after the company reported the FDA approval of OGSIVEO (nirogacestat) as the first and only treatment for adults with desmoid tumors. SpringWorks Therapeutics shares rose 14.4% to $23.77 in pre-market trading

Related Keywords

Singapore ,Redhill Biopharma ,Starbox Group Holdings Ltd ,Maxim Group ,Mobiquity Technologies Inc ,Cohbar Inc ,Alithya Group Inc ,Singapore Refining Company Private ,Bioscience Inc ,Springworks Therapeutics Inc ,Diversity Network Inc ,Icahn School Of Medicine At Mount Sinai ,Holdings Limited ,Glucotrack Inc ,Tc Biopharm Holdings Plc ,Nexalin Technology Inc ,Tharimmune Inc ,Redhill Biopharma Ltd ,Heart Test Laboratories Inc ,Asset Entities Inc ,Senestech Inc ,Sunshine Biopharma Inc ,Springworks Therapeutics ,Works Therapeutics ,Ctest Laboratories ,Icahn School ,Mount Sinai ,Acute Myeloid ,Diversity Network ,Professional Diversity ,